İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

EMİNE RABİA KOÇ

PROFESÖR

BURSA ULUDAĞ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Nöroloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 79
  • Proje 0
  • Kitap 0
  • Bildiri 63
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 22 Q2 13 Q3 11 Q4 15
WoS (JCR) Q1 7 Q2 17 Q3 13 Q4 23
TR Index 22 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 3
Ort. yüzdelik 55.9%
Üst %1 payı 0.0%
Üst %10 payı 5.5%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 79 yayın

Scopus (SJR)
Q1 22 Q2 13 Q3 11 Q4 15
WoS (JCR)
Q1 7 Q2 17 Q3 13 Q4 23
TR Index
22 makale

Makale listesi

  1. 2026 Alemtuzumab-induced antineutrophil cytoplasmic antibody-associated nephritis in a patient with multiple sclerosis TURK NOROLOJİ DERGİSİ DOI 10.55697/tnd.2024.238 YÖKSİS TR Index OpenAlex 61.0%
  2. 2025 The postdoc paradox: a career without a path Brain DOI 10.1093/brain/awaf314 YÖKSİS SJR Q1 JCR Q1 OpenAlex 26.1%
  3. 2025 Thyroid comorbidities do not seem to negatively impact multiple sclerosis course: A single centre cohort study Multiple Sclerosis and Related Disorders DOI 10.1016/j.msard.2025.106323 YÖKSİS SJR Q1 JCR Q2 OpenAlex 64.0%
  4. 2025 Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of life Neurological Sciences DOI 10.1007/s10072-025-08277-6 YÖKSİS SJR Q1 JCR Q3 OpenAlex 85.9%
  5. 2025 Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape Expert Opinion on Emerging Drugs DOI 10.1080/14728214.2025.2565189 YÖKSİS SJR Q2 JCR Q2 OpenAlex 87.9%
  6. 2025 Real-world experience of ocrelizumab in patients with multiple sclerosis: A single-center study Neurology Asia DOI 10.54029/2025dsp YÖKSİS SJR Q4 JCR Q4 OpenAlex 66.5%
  7. 2025 Safety and Efficacy of Cladribine in Patients Discontinuing Fingolimod Due to Elevated Transaminase Levels: The FinClad Study Multiple Sclerosis and Related Disorders DOI 10.1016/j.msard.2025.106578 YÖKSİS SJR Q1 JCR Q2 OpenAlex 80.2%
  8. 2025 Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study Journal of Neurology DOI 10.1007/s00415-025-13425-1 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.5%
  9. 2025 Relationship of cranial bone signal intensity to multiple sclerosis clinical course and progression Science Progress DOI 10.1177/00368504251336090 YÖKSİS SJR Q1 JCR Q2 OpenAlex 10.8%
  10. 2025 Academia in the throes of faceless bureaucracy Brain DOI 10.1093/brain/awaf217 YÖKSİS SJR Q1 JCR Q1 OpenAlex 14.9%
  11. 2025 Determinants of health literacy and its impact on illness perception in patients with multiple sclerosis: evidence from patient-reported outcomes BMJ Neurology Open DOI 10.1136/bmjno-2025-0014411. YÖKSİS SJR Q2 JCR Q3
  12. 2025 The effect of fingolimod on complete blood count, lipid panel, and relationship with clinicoradiologic features in patients with multiple sclerosis Turkish Journal of Neurology DOI 10.55697/tnd.2025.213 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 57.5%
  13. 2024 Evaluation of risk factors for postpartum cerebral venous sinus thrombosis, a multicenter retrospective observational study Medicine DOI 10.1097/MD.0000000000040772 YÖKSİS SJR Q3 JCR Q2 OpenAlex 61.0%
  14. 2024 Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience Multiple Sclerosis and Related Disorders DOI 10.1016/j.msard.2024.105948 YÖKSİS SJR Q1 JCR Q2 OpenAlex 74.0%
  15. 2024 Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study Multiple Sclerosis and Related Disorders DOI 10.1016/j.msard.2024.105939 YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.5%
  16. 2024 Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study Clinical Rheumatology DOI 10.1007/s10067-024-07118-9 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 93.8%
  17. 2024 Characteristics of Cerebral Venous Sinus Thrombosis Due to Autoimmune Diseases: A Single-Center Retrospective Observational Study The Neurologist DOI 10.1097/NRL.0000000000000555 YÖKSİS SJR Q3 JCR Q4 OpenAlex 1.2%
  18. 2024 Covid-19 infection as a possible risk factor for longitudinally extensive transverse myelitis! Int J Neurosci . DOI 10.1080/00207454.2022.2098731 YÖKSİS SJR Q2 JCR Q4 OpenAlex 43.7%
  19. 2024 CLIPPERS Syndrome Neurological Sciences and Neurophysiology DOI 10.4103/nsn.nsn_25_23 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 55.7%
  20. 2024 Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology Multiple Sclerosis and Related Disorders DOI 10.1016/j.msard.2024.105537 YÖKSİS SJR Q1 JCR Q2 OpenAlex 51.2%

Akademisyenlere dön